Stewart immediately broke at the reference, bursting into laughter as he jumped out of his chair and took a few steps around ...

Biologics targeting interleukin-12, -23, and -17 were associated with a lower rate of serious infections among older adults ...

JAK inhibitor Xeljanz is one of Pfizer’s top-selling drugs, despite a ‘black box’ warning for blood clots and cancers added to its label in 2019. Now, a study designed to prove its safety ...

Pfizer has received approval from the US FDA for its rheumatoid arthritis (RA) drug, Xeljanz, which is the first approved RA treatment in a new class of medicines known as Janus kinase inhibitors ...

The drug and biotech sector has recovered over the past couple of months, following a slow start to the year, primarily due ...

Delve into the kinase inhibitors' diverse landscape, from cancer breakthroughs to autoimmune disease innovations.

Here are four perfect high-yield dividend stock picks for investors looking to follow the lead of the top money managers on ...

Investors and now Wall Street love dividend stocks, especially the high-yield variety, because they offer a significant income stream and have massive total return potential. Total return includes ...

Jon Stewart jumped out of his seat and walked around the 'The Daily Show' news desk during a cheeky conversation with Paul ...